Samuel Agresta
CIK 1748961 · Chief Medical Officer · last filed 2026-04-03
Samuel Agresta is a Chief Medical Officer who has filed 14 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for OKUR, was dated Apr 3, 2026. Across all open-market trades the lifetime net is −$2.6M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
14
-$2.57M
Holdings By Company
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-03 | OKUR | Grant (A) | — | $0 | EDGAR |
| 2025-01-29 | OKUR | Grant (A) | — | $0 | EDGAR |
| 2024-10-08 | OKUR | Grant (A) | — | $0 | EDGAR |
| 2023-09-13 | FHTX | — | — | $0 | EDGAR |
| 2023-08-18 | FHTX | Mixed | — | -$1.41M | EDGAR |
| 2023-01-30 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2022-06-16 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-28 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2021-06-11 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-01 | FHTX | Grant (A) | — | $0 | EDGAR |